Product Code: GVR-4-68038-639-4
Micro Syringes Market Growth & Trends:
The global micro syringes market size is expected to reach USD 352.8 million by 2030, registering a CAGR of 6.2% from 2023 to 2030, according to a new report by Grand View Research, Inc. The market is growing due to the increased quantity of life science research investigations. It is projected that the market will be driven by an increasing number of drug observations, preclinical research, and clinical trials due to pharmaceutical and biomedical companies' increased attempts to produce efficient products. The need for micro syringes is growing due to the pharmaceutical industry's extensive research efforts to create new medications.
Government funding for primary and initial researches also promotes commercial expansion. For instance, recently, there has been a noticeable diversity and increase of the injectable eye drug pipeline. This extension also includes a greater range of dose frequencies, additional delivery channel options (such as suprachoroidal and subretinal), and other target disorders (such as global atrophy and diabetic macular edema). As a result, new delivery requirements have arisen, such as limiting silicone that leaches, handling viscous formulations, and attaining microliter dose accuracy.
Micro Syringes Market Report Highlights:
- Based on syringe type, the autosampler syringes segment accounted for the largest revenue share of over 60.0% in 2022, and is expected to grow at the fastest CAGR of 6.4% over the forecast period. Due to the growing acceptance of precision autosamplers, the market is growing
- Based on end-use, the hospitals segment accounted for the largest revenue share of around 47.0% in 2022. Different types of micro syringes are frequently needed in hospitals to accommodate various medical specializations, including diagnostics, anesthesia, and oncology
- The outpatient facilities segment is expected to grow at the fastest CAGR of 6.5% over the forecast period. The growing tendency toward ambulatory services and outpatient care is in line with the flexibility and convenience of outpatient facilities
- North America dominated the market with a revenue share of over 40.0% due to the rising prevalence of chronic illnesses and advancements in healthcare technologies. Asia Pacific is anticipated to grow at the fastest CAGR of 7.6% over the forecast period with countries such as China and India serving as significant centers for pharmaceutical production and research
Table of Contents
Chapter 1. Methodology and Scope
- 1.1. Market Segmentation & Scope
- 1.1.1. Syringe type
- 1.1.2. End-use
- 1.1.3. Regional scope
- 1.1.4. Estimates and forecast timeline
- 1.2. Research Methodology
- 1.3. Information Procurement
- 1.3.1. Purchased database
- 1.3.2. GVR's internal database
- 1.3.3. Secondary sources
- 1.3.4. Primary research
- 1.3.5. Details of primary research
- 1.4. Information or Data Analysis
- 1.5. Market Formulation & Validation
- 1.6. Model Details
- 1.7. List of Secondary Sources
- 1.8. List of Primary Sources
- 1.9. Objectives
Chapter 2. Executive Summary
- 2.1. Market Outlook
- 2.2. Segment Outlook
- 2.2.1. Syringe type outlook
- 2.2.2. End-use outlook
- 2.2.3. Regional outlook
- 2.3. Competitive Insights
Chapter 3. Micro Syringes Market Variables, Trends & Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Parent market outlook
- 3.1.2. Related/ancillary market outlook
- 3.2. Penetration & Growth Prospect Mapping
- 3.3. Market Dynamics
- 3.3.1. Market driver analysis
- 3.3.2. Market restraint analysis
- 3.3.3. Market opportunities analysis
- 3.3.4. Market challenges analysis
- 3.4. Micro Syringes Market Analysis Tools
- 3.4.1. Industry Analysis - Porter's
- 3.4.1.1. Supplier power
- 3.4.1.2. Buyer power
- 3.4.1.3. Substitution threat
- 3.4.1.4. Threat of new entrant
- 3.4.1.5. Competitive rivalry
- 3.4.2. PESTEL Analysis
- 3.4.2.1. Political landscape
- 3.4.2.2. Technological landscape
- 3.4.2.3. Economic landscape
Chapter 4. Micro Syringes: Syringes Type Estimates & Trend Analysis
- 4.1. Micro Syringes Market: Key Takeaways
- 4.2. Micro Syringes Market: Movement & Market Share Analysis, 2022 & 2030
- 4.3. Autosampler Syringes
- 4.3.1. Autosampler syringes market estimates and forecasts, 2018 to 2030 (USD Million)
- 4.4. Manual Syringes
- 4.4.1. Manual syringes market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 5. Micro Syringes: End-use Estimates & Trend Analysis
- 5.1. Micro Syringes Market: Key Takeaways
- 5.2. Micro Syringes Market: Movement & Market Share Analysis, 2022 & 2030
- 5.3. Hospitals
- 5.3.1. Hospitals market estimates and forecasts, 2018 to 2030 (USD Million)
- 5.4. Outpatient Facilities
- 5.4.1. Outpatient Facilities market estimates and forecasts, 2018 to 2030 (USD Million)
- 5.5. Research and Manufacturing
- 5.5.1. Research and Manufacturing market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 6. Micro Syringes Market: Regional Estimates & Trend Analysis
- 6.1. Regional Outlook
- 6.2. Micro Syringes Market by Region: Key Takeaway
- 6.3. North America
- 6.3.1. U.S.
- 6.3.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.3.2. Canada
- 6.3.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.4. Europe
- 6.4.1. UK
- 6.4.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.4.2. Germany
- 6.4.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.4.3. France
- 6.4.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.4.4. Italy
- 6.4.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.4.5. Spain
- 6.4.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.4.6. Sweden
- 6.4.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.4.7. Norway
- 6.4.7.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.4.8. Denmark
- 6.4.8.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.5. Asia Pacific
- 6.5.1. Japan
- 6.5.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.5.2. China
- 6.5.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.5.3. India
- 6.5.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.5.4. Australia
- 6.5.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.5.5. Thailand
- 6.5.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.5.6. South Korea
- 6.5.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.6. Latin America
- 6.6.1. Brazil
- 6.6.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.6.2. Mexico
- 6.6.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.6.3. Argentina
- 6.6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.7. MEA
- 6.7.1. Saudi Arabia
- 6.7.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.7.2. South Africa
- 6.7.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.7.3. UAE
- 6.7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.7.4. Kuwait
- 6.7.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
Chapter 7. Competitive Landscape
- 7.1. Recent Developments & Impact Analysis, By Key Market Participants
- 7.2. Market Participant Categorization
- 7.2.1. Innovative Labor Systeme (ILS)
- 7.2.1.1. Company overview
- 7.2.1.2. Financial performance
- 7.2.1.3. Product benchmarking
- 7.2.1.4. Strategic initiatives
- 7.2.2. GL Science, Inc.
- 7.2.2.1. Company overview
- 7.2.2.2. Financial performance
- 7.2.2.3. Product benchmarking
- 7.2.2.4. Strategic initiatives
- 7.2.3. Hamilton Company
- 7.2.3.1. Company overview
- 7.2.3.2. Financial performance
- 7.2.3.3. Product benchmarking
- 7.2.3.4. Strategic initiatives
- 7.2.4. PerkinElmer, Inc.
- 7.2.4.1. Company overview
- 7.2.4.2. Financial performance
- 7.2.4.3. Product benchmarking
- 7.2.4.4. Strategic initiatives
- 7.2.5. Shimadzu Corporation
- 7.2.5.1. Company overview
- 7.2.5.2. Financial performance
- 7.2.5.3. Product benchmarking
- 7.2.5.4. Strategic initiatives
- 7.2.6. Trajan Scientific and Medical
- 7.2.6.1. Company overview
- 7.2.6.2. Financial performance
- 7.2.6.3. Product benchmarking
- 7.2.6.4. Strategic initiatives
- 7.2.7. Avantor
- 7.2.7.1. Company overview
- 7.2.7.2. Financial performance
- 7.2.7.3. Product benchmarking
- 7.2.7.4. Strategic initiatives
- 7.2.8. Zoetis Services
- 7.2.8.1. Company overview
- 7.2.8.2. Financial performance
- 7.2.8.3. Product benchmarking
- 7.2.8.4. Strategic initiatives
- 7.2.9. Valco Instruments Company Inc.
- 7.2.9.1. Company overview
- 7.2.9.2. Financial performance
- 7.2.9.3. Product benchmarking
- 7.2.9.4. Strategic initiatives
- 7.2.10. Agilent Technologies Inc
- 7.2.10.1. Company overview
- 7.2.10.2. Financial performance
- 7.2.10.3. Product benchmarking
- 7.2.10.4. Strategic initiatives